Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Depreciation & Amortization (CF) (2013 - 2026)

Xencor (XNCR) posted quarterly Depreciation & Amortization (CF) of $2.6 million for Q1 2026, down 4.68% year-over-year from $2.7 million in Q1 2025, and little changed quarter-over-quarter from $2.6 million in Q4 2025.

Analysis

Xencor (XNCR) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Depreciation & Amortization (CF) for 14 consecutive years, with $2.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Depreciation & Amortization (CF) fell 4.68% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $10.4 million (down 11.72% YoY), while the FY2025 annual figure was $10.5 million, down 13.17% from the prior year.
  • Depreciation & Amortization (CF) steadied at $2.6 million in Q1 2026 per XNCR's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $3.2 million in Q4 2023 and bottomed at $2.2 million in Q4 2022.
  • Historically, Depreciation & Amortization (CF) has averaged $2.7 million across 5 years, with a median of $2.7 million in 2025.
  • Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) jumped 49.51% — and 2025, when it dropped 15.23%.
  • Xencor's Depreciation & Amortization (CF) stood at $2.2 million in 2022, then jumped by 49.51% to $3.2 million in 2023, then dropped by 7.25% to $3.0 million in 2024, then declined by 13.93% to $2.6 million in 2025, then fell by 0.39% to $2.6 million in 2026.
  • Business Quant data shows XNCR's Depreciation & Amortization (CF) at $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Xencor 2.02 Bn 1.65 Bn - 2.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.44 Mn
Mar 31, 2026 2.57 Mn
Dec 31, 2025 2.58 Mn
Sep 30, 2025 2.59 Mn
Jun 30, 2025 2.65 Mn
Mar 31, 2025 2.69 Mn
Dec 31, 2024 2.99 Mn
Sep 30, 2024 3.05 Mn
Jun 30, 2024 3.02 Mn
Mar 31, 2024 3.04 Mn
Dec 31, 2023 3.23 Mn
Sep 30, 2023 3.14 Mn
Jun 30, 2023 2.89 Mn
Mar 31, 2023 2.25 Mn
Dec 31, 2022 2.16 Mn
Sep 30, 2022 2.24 Mn
Jun 30, 2022 2.22 Mn
Mar 31, 2022 2.18 Mn
Dec 31, 2021 2.11 Mn
Sep 30, 2021 1.99 Mn